Question: A 17-year-old Algerian girl who had lived in France for 2 years was referred to our dermatologic unit for a painful infiltrated crusty cheilitis. She was under anti-tumor necrosis factor-a (anti-TNF-a) therapy for active Crohn disease (CD). CD was diagnosed in 2011 on rectal bleeding, weight loss and ileal ulcerations at colonoscopy. She was previously treated with 5-ASA and azathioprine without efficacy. Adalimumab was introduced in May 2015 after a pretherapeutic evaluation that included negative interferon-gamma release assay (IGRA). Dose of adalimumab was majored to 40 mg per week in December 2015 because her CD remained active. Four months later, labial lesions appeared, with edema and vesicles, and progressed to a painful infiltrated and crusty cheilitis. Antibiotics and valaciclovir treatments were unsuccessful. Oral examination revealed a unilateral cobblestone aspect with pustules on the lip mucosa without affecting the rest of oral cavity (Figure A, B). A centimetric right cervical adenopathy was noticed. She did not have any other complaints, and the rest of physical findings were normal. Laboratory results from blood chemistry, complete blood cell count, liver, and kidney analysis were within reference range. C-reactive protein was elevated (117 mg/L). Infectious workup (human immunodeficiency virus and syphilitic serology, leishmania, and herpes polymerase chain reaction) was negative. Standard chest radiography was normal. Magnetic resonance enterography revealed an asymptomatic terminal ileitis with an enhancement of the submucosa. Labial biopsies showed an epithelioid and giant cell granuloma without caseous necrosis (Figure C); Ziehl-Neelsen, Grocott and periodic acid-Schiff stains were negative for acid-fast bacilli and fungi, respectively. No viral inclusion body was seen. What is the diagnosis? Look on page 1240 for the answer and see the Gastroenterology website (www.gastrojournal.org) for more information on submitting your favorite image to Clinical Challenges and images in GI.